Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults.
Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults.
复制标题
DOI：
10.1016/j.cct.2021.106593
复制
发表时间：
2021-12
影响因子：
2.2
通讯作者：
McClure JB
中科院分区：
文献类型：
--
作者：
Rosenberg DE;Greenwood-Hickman MA;Zhou J;Cook AJ;Mettert KD;Cooper J;Arterburn D;Green BB;Walsh-Bailey C;Kerr J;Owen N;Dunstan D;McClure JB
患有肥胖症的老年人醒着的大部分时间都是久坐不动的。鉴于这一人群经常进行身体活动的巨大障碍，减少久坐时间的方法可能是一种有效的健康促进策略。我们提出了一项随机对照试验的协议，以减少身体质量指数为30 kg/m2或以上的老年人的坐着时间。参与者（N = 284）将随机接受坐姿减少干预（称为I-STAND）或健康生活集中注意力控制条件。I-STAND包括与健康教练的10次联系（总共10次），参与者将获得一个腕戴式提示设备和便携式站立桌。健康生活条件包括与健康教练的10次会议，围绕与健康老龄化有关的各种主题设定目标。参与者接受指定的干预6个月。6个月后，那些接受I-STAND条件的人被重新随机分配，通过电话或不再联系接受五次加强健康辅导课程;健康生活参与者不再接受进一步联系，并且对这两种条件的参与者进行额外6个月的随访。测量最初包括佩戴activePAL设备并完成几项生物特征测试（例如，在基线、3个月、6个月和12个月时，我们对所有患者进行了血压（HbA 1c）评估;然而，在COVID-19大流行期间，我们转向远程评估，无法收集所有这些指标。主要结局仍然是activePAL评估的坐位时间和血压。招聘工作预计将于2022年完成。
Older adults with obesity spend the majority of their waking hours sedentary. Given substantial barriers to regular physical activity in this population, approaches to reduce sedentary time could be an effective health promotion strategy. We present the protocol of a randomized controlled trial to reduce sitting time in older adults with a body mass index of 30 kg/m2 or above. Participants (N = 284) will be randomized to receive a sitting reduction intervention (termed I-STAND) or a healthy living focused attention control condition. I-STAND includes 10 contacts with a health coach (10 sessions total) and participants receive a wrist-worn prompting device and portable standing desk. The healthy living condition includes 10 sessions with a health coach to set goals around various topics relating to healthy aging. Participants receive their assigned intervention for 6 months. After 6 months, those receiving the I-STAND condition are re-randomized to receive five booster health coaching sessions by ‘phone or no further contact; healthy living participants receive no further contact and those in both conditions are followed for an additional 6 months. Measurements initially included wearing an activPAL device and completing several biometric tests (e.g., blood pressure, HbA1c), at baseline, 3 months, 6 months, and 12 months; however, during the COVID-19 pandemic we shifted to remote assessments and were unable to collect all of these measures. The primary outcomes remained activPAL-assessed sitting time and blood pressure. Recruitment is anticipated to be completed in 2022.
登录
查看更多内容
影响因子：
7.6
作者：
BARON, RM;KENNY, DA
通讯作者：
KENNY, DA
影响因子：
3.9
作者：
Browne RAV;Macêdo GAD;Cabral LLP;Oliveira GTA;Vivas A;Fontes EB;Elsangedy HM;Costa EC
通讯作者：
Costa EC
影响因子：
6.9
作者：
Chastin, Sebastien F. M.;Egerton, Thorlene;Stamatakis, Emmanuel
通讯作者：
Stamatakis, Emmanuel
DOI：
10.1249/mss.0000000000002249
发表时间：
2020-06-01
期刊：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
影响因子：
--
作者：
Henson, Joseph;Edwardson, Charlotte L.;Yates, Thomas
通讯作者：
Yates, Thomas
影响因子：
--
作者：
Bandura, Albert
通讯作者：
Bandura, Albert